Evidence map›Paper›PMID 26064077›Full record

ArticleSarcoma2015

The Use of Radiation Therapy in Well-Differentiated Soft Tissue Sarcoma of the Extremities: An NCDB Review.

Alexander L Lazarides, William C Eward, Paul J Speicher, Chun-Han Hou, Daniel P Nussbaum, Cindy Green, Dan G Blazer, David G Kirsch, Brian E Brigman

Open access · hybridAbstract read
In one paragraph

Article in Sarcoma, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Epigenetics of Cutaneous Sarcoma.International journal of molecular sciences · 2021
    Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Alexander L LazaridesSchool of Medicine, Duke University, Durham, NC 27710, USA.
William C EwardDepartment of Surgery, Division of Orthopedic Surgery, Duke University Medical Center, Durham, NC 27710, USA.
Paul J SpeicherDepartment of Surgery, Duke University Medical Center, Durham, NC 27710, USA.
Chun-Han HouDepartment of Orthopedic Surgery, National Taiwan University Hospital, Taipei 10617, Taiwan.
Daniel P NussbaumDepartment of Surgery, Duke University Medical Center, Durham, NC 27710, USA.
Cindy GreenDepartment of Surgery, Division of Orthopedic Surgery, Duke University Medical Center, Durham, NC 27710, USA.
Dan G BlazerDepartment of Surgery, Duke University Medical Center, Durham, NC 27710, USA.
David G KirschDepartment of Radiation Oncology, Duke University Medical Center, Durham, NC 27710, USA.
Brian E BrigmanDepartment of Surgery, Division of Orthopedic Surgery, Duke University Medical Center, Durham, NC 27710, USA.
Duke Medical Center · USDuke University Hospital · USDuke University · USNational Taiwan University Hospital · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective. This study investigated patterns of utilization of radiation therapy (RT) and correlated this with overall survival by assessing patients with well-differentiated soft tissue sarcoma of the extremity (STS-E) in the National Cancer Database (NCDB). Methods. All patients diagnosed with well-differentiated STS-E between 1998 and 2006 were identified in the NCDB. Patients were stratified by use of surgery alone versus use of adjuvant RT after surgery and analyzed using multivariate analysis, Kaplan-Meier analysis, and propensity matching. Results. 2113 patients with well-differentiated STS-E were identified in the NCDB for inclusion with a mean follow-up time of 74 months. 69% of patients were treated with surgery alone, while 26% were treated with surgery followed by adjuvant RT. Patients undergoing amputation were less likely to receive adjuvant RT. There was no difference in overall survival between patients with well-differentiated STS treated with surgery alone and those patients who received adjuvant RT. Conclusions. In the United States, adjuvant RT is being utilized in a quarter of patients being treated for well-differentiated STS-E. While the use of adjuvant RT may be viewed as a means to facilitate limb salvage, this large national database review confirms no survival benefit, regardless of tumor size or margin status.

Identifiers

PMID26064077
PMCPMC4439510
OpenAlexW1579503369

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.